Investing in Assured Med Supply means joining an AI revolution in healthcare supply chain management - a $1 Trillion market with high margins and long- term potential. Their AMS.AI platform solves a major pain point for hospitals: huge purchasing and reporting inefficiencies in supply chain. It tackles hospitals' second-largest expense, which can exceed $600M per hospital. The team's track record is stellar. Their last startup they founded is now a world leader for their market and manages $9B in assets. Previously, they built a supply chain startup ranked the fastest-growing in America by Inc. 5000. This expertise, combined with cutting-edge AI capabilities, positions this team to transform hospital supply chains. Beyond profits, there's a huge impact investment angle they're not advertising. AMS.AI is not just made for the biggest most successful hospitals but can directly prevent smaller rural hospitals from shutting down (Most people don't realize 30% are in danger of shut down due to financial issues), saving healthcare for millions of people and saving lives. As a seasoned investor and myself a co-founder of a successful Silicon Valley tech company, I rarely see opportunities combining proven leadership, game-changing technology, and massive market need like this. Assured Med Supply isn't just a smart investment; it's a chance to be part of a healthcare & AI revolution.